|
|
 |
|
Townsend Letter for Doctors and Patients, May, 2002 by
Tori Hudson
Forty-six men and forty-four women aged 18-69 with recurrent
genital herpes simplex virus type 2, participated in a single-blind,
randomized controlled multi-center trial. Patients were treated
during an active outbreak with either a 3% propolis
ointment, 5% acyclovir ointment, or placebo ointment four times
daily for 10 days. Patients were examined on day 1, day 3, day
7 and day 10 of treatment. Lesions were noted for location, number,
size and stage. They were classified as vesicular, ulcerated,
crusted or healed. Laboratory and clinical examinations were conducted.
Both groups were considered equal for the stage of the lesion
at initial examination and the nature of the symptoms. On day
3 of the treatment, 50% on propolis
ointment, 27% on acyclovir and 0% taking placebo had crusted lesions.
On day 7, and of the patients who had ulcerations, 10 taking propolis,
4 taking acyclovir and 3 taking placebo were healed. On day 10
of the treatment, and of the patients who initially had ulcerations,
100% were healed in the propolis group, 80% in the acyclovir group
and 70% in the placebo group were healed. In the group with initial
vesicular lesions, more patients had healed completely in the
propolis group (50%) than in the acyclovir group (13%) and placebo
group (25%) together. When the overall treatment was completed
after 10 days, 24/30 patients had healed in the propolis group,
14/30 in the acyclovir group and 12/30 in the placebo group. No
adverse effects related to the medication were noted in any of
the groups at any of the examinations.
Comment: Genital herpes is the most common sexually transmitted disease in
the developed world. Of women visiting gynecological clinics,
2-6% exhibit genital herpetic infections. Recurrent genital herpes
infections can be difficult to treat. Topical treatments used
acutely and systemic treatments used in the interim as well as
acutely, are an excellent combined approach. Topical acyclovir,
topical lemon balm and topical lysine have been used with some
success. We now have another not only viable option, but perhaps
preferable. Propolis is rich in flavonoids
that have demonstrable anti-viral properties in vitro. Propolis
exhibits its antimicrobial effects by inhibiting cell division,
disorganizing the cytoplasmic membrane in the cell wall and inhibiting
protein synthesis. The exact mechanism beyond these issues is
not fully understood.
Vynograd N, Bynograd I, Seonewski Z. A comparative
multi-centre study of the efficacy of propolis, acyclovir
and placebo in the treatment of genital herpes (HSV).Phytomedicine
2000; 7(1):1:1-6.
|
|
 |
COPYRIGHT 2002 The Townsend Letter Group
COPYRIGHT 2002 Gale Group |
|
 |
|